open access

Vol 47, No 3 (2015)
Review articles
Submitted: 2015-07-09

The use of nalbuphine in paediatric anaesthesia

Anna Kubica-Cielińska, Marzena Zielińska
DOI: 10.5603/AIT.2015.0036
·
Anaesthesiol Intensive Ther 2015;47(3):252-256.

open access

Vol 47, No 3 (2015)
Review articles
Submitted: 2015-07-09

Abstract

Nalbuphine is an agonist-antagonist opioid. It causes analgesic and sedative effect and because of ceiling effect it does not cause a respiratory depression. In a perioperative therapy of paediatric patients it may be used for premedication, sedation during diagnostic procedures as well as for postoperative pain treatment. It reverses adverse reactions of other opioids such as itch or urinary retention, not significantly influencing its analgetic properties. After sevoflurane anaesthesia of small children, it reduces the incidences of emergence agitation. Nalbuphine is considered a safe drug, which causes nausea and vomiting less frequently than other opioids. Analgesic effect, the ability to provide moderate sedation and a large margin of safety make that analgesic often used for paediatric patients.

Keywords

postoperative analgesia, nalbuphine, children

About this article
Title

The use of nalbuphine in paediatric anaesthesia

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 47, No 3 (2015)

Pages

252-256

DOI

10.5603/AIT.2015.0036

Bibliographic record

Anaesthesiol Intensive Ther 2015;47(3):252-256.

Keywords

postoperative analgesia
nalbuphine
children

Authors

Anna Kubica-Cielińska
Marzena Zielińska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl